The natural history of left ventricular wall thickening in hypertrophic cardiomyopathy

Australian and New Zealand Journal of Medicine

Volumn 27, Issue 1, 1997, Pages 51-58

  Semsarian, C ^a   French, J ^a   Trent, R J ^a   Richmond, D R ^a   Jeremy, R W ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Age; Echocardiography; Growth; Hypertrophic cardiomyopathy

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODYNAMICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE;

EID: 0030893163     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1997.tb00914.x     Document Type: Article

References (29)

1. Maron BJ, Nichols PF, Pickle LW, Wesley YE, Mulvihill JJ. Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol 1984; 53: 1087-94.
2. Maron BJ et al. Hypertrophic cardiomyopathy: a common cause of sudden death in the young competitive athlete. Eur Heart J 1983; 4: 135-42.
3. Hejtmancik JF, Brink PA, Towbin J et al. Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse US population. Circulation 1991; 83: 1592-7.
4. Arg-Glu mutation. Circulation 1992; 86: 345-52.
5. Solomon SD, Wolff S, Watkins H et al. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol 1993; 22: 498-505.
6. Geisterfer-Lowrance AAT, Kass S, Tanigawa G et al. A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain missense mutation. Cell 1990; 62: 999-1006.
7. Thierfelder L, Watkins H, MacRae C et al. α-Tropomyosin and cardiac troponin t mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 1994; 77: 701-12.
8. Marian AJ, Roberts RA. Molecular genetics of cardiomyopathies. Herz. 1993; 18: 230-7.
9. Bonne G, Carrier L, Bercovici J et al. Cardiac myosin binding protein-c gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature Genetics 1995; 11: 438-40.
10. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Circulation 1994; 89: 22-32.
11. Ciro E, Nichols PF, Maron BJ. Heterogenous morphologic expression of genetically transmitted hypertrophic cardiomyopathy: two-dimensional echocardiographic analysis. Circulation 1983; 67: 1227-33.
12. Parker TG, Schneider MD. Growth factors, protooncogenes, and plasticity of the cardiac phenotype. Annu Rev Physiol 1991; 53: 179-200.
13. Lompre AM, Nadal-Ginard B, Mahdavi V. Expression of the cardiac ventricular α- and β-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem 1984; 259: 6437-46.
14. Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 1986; 315: 610-4.
15. Spirito P, Maron BJ. Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1987; 9: 1013-7.
16. Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989; 320: 749-55.
17. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-67.
18. Glantz SA. Primer of Biostatistics. 2nd edn. New York, NY: McGraw Hill, 1987.
19. Statpak Statistical Software Package. Version 4.11 Northwest Analytical Inc. Portland, Oregon, 1986.
20. Gregor P, Widimsky P. The course of myocardial hypertrophy in hypertrophic cardiomyopathy. Results of a 10-year follow-up. Cor et Vasa 1993; 35: 108-15.
21. Hina K, Kusachi S, Iwasaki K et al. Progression of left ventricular enlargement in patients with hypertrophic cardiomyopathy: incidence and prognostic value. Clin Cardiol 1993; 16: 403-7.
22. Ojamaa K, Samarel AM, Kupfer JM, Hong C, Klein I. Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis. Am J Physiol 1992; 263: E534-E540.
23. St John Sutton MG, Marier DL, Oldershaw PJ, Sacchetti R, Gibson DG. Effect of age related changes in chamber size, wall thickness, and heart rate on left ventricular function in normal children. Br Heart J 1982; 48: 342-51.
24. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 1990; 259: H610-H618.
25. Kojima M, Shiojima I, Yamazaki T et al. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signalling pattern of stretchmediated cardiomyocyte hypertrophy. Circulation 1994; 89: 2204-11.
26. Re RN. Myocardial hypertrophy, angiotensin, and ACE inhibitors. Angiology 1993; 875-81.
27. Yu B, Richmond D, Jeremy R et al. Angiotensin converting enzyme gene polymorphism in familial hypertrophic cardiomyopathy patients. Am J Hum Genet 1994; 55: A208 (Abstr.).
28. Schunkert H, Hense H-W, Holmer SR et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-8.
29. Lechin M, Quinones M, Omran A et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995; 92: 1808-12.